AI Science Tracker
EN

Enriching the Study Population for Ischemic Stroke Therapeutic Trials Using a Machine Learning Algorithm.

Affiliation not stated in the reviewed material · 25 Jan 2022 · medicine

Discovery

Enriching the Study Population for Ischemic Stroke Therapeutic Trials Using a Machine Learning Algorithm.

Source check: Source checked. Not independent scientific confirmation.

Finding: Gradient boosting identified ischemic-stroke patients likely to have a future event in a trial-relevant time window, evaluating cohort enrichment on linked health records. Organization is unavailable in the deposited bibliographic metadata.

Technology: Gradient-boosting model for stroke cohort enrichment

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods train gradient boosting to predict ischemic stroke within one year; Results assess selection/enrichment performance in a large claims dataset.
Test and result
Gradient boosting identified ischemic-stroke patients likely to have a future event in a trial-relevant time window, evaluating cohort enrichment on linked health records.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8823366/

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.